233 related articles for article (PubMed ID: 15668438)
1. Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation.
Asanuma K; Ma Y; Okulski J; Dhawan V; Chaly T; Carbon M; Bressman SB; Eidelberg D
Neurology; 2005 Jan; 64(2):347-9. PubMed ID: 15668438
[TBL] [Abstract][Full Text] [Related]
2. Abnormal striatal and thalamic dopamine neurotransmission: Genotype-related features of dystonia.
Carbon M; Niethammer M; Peng S; Raymond D; Dhawan V; Chaly T; Ma Y; Bressman S; Eidelberg D
Neurology; 2009 Jun; 72(24):2097-103. PubMed ID: 19528516
[TBL] [Abstract][Full Text] [Related]
3. Impaired sequence learning in dystonia mutation carriers: a genotypic effect.
Carbon M; Argyelan M; Ghilardi MF; Mattis P; Dhawan V; Bressman S; Eidelberg D
Brain; 2011 May; 134(Pt 5):1416-27. PubMed ID: 21515903
[TBL] [Abstract][Full Text] [Related]
4. Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride.
Hirvonen J; Aalto S; Lumme V; Någren K; Kajander J; Vilkman H; Hagelberg N; Oikonen V; Hietala J
Nucl Med Commun; 2003 Dec; 24(12):1207-14. PubMed ID: 14627846
[TBL] [Abstract][Full Text] [Related]
5. Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET.
Hirvonen J; Karlsson H; Kajander J; Markkula J; Rasi-Hakala H; Någren K; Salminen JK; Hietala J
Psychopharmacology (Berl); 2008 May; 197(4):581-90. PubMed ID: 18251011
[TBL] [Abstract][Full Text] [Related]
6. Striatal dopaminergic dysfunction at rest and during task performance in writer's cramp.
Berman BD; Hallett M; Herscovitch P; Simonyan K
Brain; 2013 Dec; 136(Pt 12):3645-58. PubMed ID: 24148273
[TBL] [Abstract][Full Text] [Related]
7. Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice.
Yokoi F; Oleas J; Xing H; Liu Y; Dexter KM; Misztal C; Gerard M; Efimenko I; Lynch P; Villanueva M; Alsina R; Krishnaswamy S; Vaillancourt DE; Li Y
Neurobiol Dis; 2020 Feb; 134():104638. PubMed ID: 31618684
[TBL] [Abstract][Full Text] [Related]
8. Opioid binding in DYT1 primary torsion dystonia: an 11C-diprenorphine PET study.
Whone AL; Von Spiczak S; Edwards M; Valente EM; Hammers A; Bhatia KP; Brooks DJ
Mov Disord; 2004 Dec; 19(12):1498-503. PubMed ID: 15390064
[TBL] [Abstract][Full Text] [Related]
9. Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia.
Pisani A; Martella G; Tscherter A; Bonsi P; Sharma N; Bernardi G; Standaert DG
Neurobiol Dis; 2006 Nov; 24(2):318-25. PubMed ID: 16934985
[TBL] [Abstract][Full Text] [Related]
10. Defective temporal processing of sensory stimuli in DYT1 mutation carriers: a new endophenotype of dystonia?
Fiorio M; Gambarin M; Valente EM; Liberini P; Loi M; Cossu G; Moretto G; Bhatia KP; Defazio G; Aglioti SM; Fiaschi A; Tinazzi M
Brain; 2007 Jan; 130(Pt 1):134-42. PubMed ID: 17105745
[TBL] [Abstract][Full Text] [Related]
11. Striatal D2 receptors in symptomatic and asymptomatic carriers of dopa-responsive dystonia measured with [11C]-raclopride and positron-emission tomography.
Kishore A; Nygaard TG; de la Fuente-Fernandez R; Naini AB; Schulzer M; Mak E; Ruth TJ; Calne DB; Snow BJ; Stoessl AJ
Neurology; 1998 Apr; 50(4):1028-32. PubMed ID: 9566390
[TBL] [Abstract][Full Text] [Related]
12. Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia.
Kubota M; Nagashima T; Takano H; Kodaka F; Fujiwara H; Takahata K; Moriguchi S; Kimura Y; Higuchi M; Okubo Y; Takahashi H; Ito H; Suhara T
Int J Neuropsychopharmacol; 2017 Nov; 20(11):928-935. PubMed ID: 29016872
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the direct pathway in Dyt1 ΔGAG heterozygous knock-in mice and dopamine receptor 1-expressing-cell-specific Dyt1 conditional knockout mice.
Yokoi F; Chen HX; Oleas J; Dang MT; Xing H; Dexter KM; Li Y
Behav Brain Res; 2021 Aug; 411():113381. PubMed ID: 34038798
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography study of human narcolepsy: no increase in striatal dopamine D2 receptors.
Rinne JO; Hublin C; Partinen M; Ruottinen H; Ruotsalainen U; Någren K; Lehikoinen P; Laihinen A
Neurology; 1995 Sep; 45(9):1735-8. PubMed ID: 7675236
[TBL] [Abstract][Full Text] [Related]
15. D2 receptor binding in dopa-responsive dystonia.
Künig G; Leenders KL; Antonini A; Vontobel P; Weindl A; Meinck HM
Ann Neurol; 1998 Nov; 44(5):758-62. PubMed ID: 9818931
[TBL] [Abstract][Full Text] [Related]
16. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
[TBL] [Abstract][Full Text] [Related]
17. Opposing patterns of abnormal D1 and D2 receptor dependent cortico-striatal plasticity explain increased risk taking in patients with DYT1 dystonia.
Gilbertson T; Arkadir D; Steele JD
PLoS One; 2020; 15(5):e0226790. PubMed ID: 32365120
[TBL] [Abstract][Full Text] [Related]
18. Dopamine release is impaired in a mouse model of DYT1 dystonia.
Balcioglu A; Kim MO; Sharma N; Cha JH; Breakefield XO; Standaert DG
J Neurochem; 2007 Aug; 102(3):783-8. PubMed ID: 17550429
[TBL] [Abstract][Full Text] [Related]
19. Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.
Vollenweider FX; Vontobel P; Oye I; Hell D; Leenders KL
J Psychiatr Res; 2000; 34(1):35-43. PubMed ID: 10696831
[TBL] [Abstract][Full Text] [Related]
20. Decreased dopamine D receptor binding in essential blepharospasm.
Horie C; Suzuki Y; Kiyosawa M; Mochizuki M; Wakakura M; Oda K; Ishiwata K; Ishii K
Acta Neurol Scand; 2009 Jan; 119(1):49-54. PubMed ID: 18540899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
